Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EZH2 inhibition: a promising strategy to prevent cancer immune editing.
Kang N, Eccleston M, Clermont PL, Latarani M, Male DK, Wang Y, Crea F. Kang N, et al. Among authors: eccleston m. Epigenomics. 2020 Aug;12(16):1457-1476. doi: 10.2217/epi-2020-0186. Epub 2020 Sep 17. Epigenomics. 2020. PMID: 32938196 Free PMC article. Review.
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib.
Salani F, Latarani M, Casadei-Gardini A, Gangadharannambiar P, Fornaro L, Vivaldi C, Pecora I, Massa V, Marisi G, Canale M, Ulivi P, Scartozzi M, Eccleston M, Masi G, Crea F. Salani F, et al. Among authors: eccleston m. Epigenomics. 2022 May;14(9):507-517. doi: 10.2217/epi-2021-0383. Epub 2022 Apr 27. Epigenomics. 2022. PMID: 35473355 Free article.
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
Bauden M, Pamart D, Ansari D, Herzog M, Eccleston M, Micallef J, Andersson B, Andersson R. Bauden M, et al. Among authors: eccleston m. Clin Epigenetics. 2015 Oct 7;7:106. doi: 10.1186/s13148-015-0139-4. eCollection 2015. Clin Epigenetics. 2015. PMID: 26451166 Free PMC article.
Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.
Cavalier E, Guiot J, Lechner K, Dutsch A, Eccleston M, Herzog M, Bygott T, Schomburg A, Kelly T, Holdenrieder S. Cavalier E, et al. Among authors: eccleston m. Front Mol Biosci. 2021 Mar 18;8:600881. doi: 10.3389/fmolb.2021.600881. eCollection 2021. Front Mol Biosci. 2021. PMID: 33816549 Free PMC article.
Academia Meets Industry.
Schäfer C, Paprotka T, Heitzer E, Eccleston M, Noe J, Holdenrieder S, Diehl F, Thierry A. Schäfer C, et al. Among authors: eccleston m. Adv Exp Med Biol. 2016;924:201-215. doi: 10.1007/978-3-319-42044-8_36. Adv Exp Med Biol. 2016. PMID: 27753044
Epidemiology of RBC Transfusions in Patients With Severe Acute Kidney Injury: Analysis From the Randomized Evaluation of Normal Versus Augmented Level Study.
Bellomo R, Mårtensson J, Kaukonen KM, Lo S, Gallagher M, Cass A, Myburgh J, Finfer S; Randomized Evaluation of Normal Versus Augmented Level of Replacement Therapy Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Bellomo R, et al. Crit Care Med. 2016 May;44(5):892-900. doi: 10.1097/CCM.0000000000001518. Crit Care Med. 2016. PMID: 26619086 Clinical Trial.
Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.
Bellomo R, Mårtensson J, Lo S, Kaukonen KM, Cass A, Gallagher M; RENAL study investigators; Australian and New Zealand Intensive Care Clinical Trials Group. Bellomo R, et al. Blood Purif. 2016;41(1-3):11-7. doi: 10.1159/000439581. Epub 2015 Oct 20. Blood Purif. 2016. PMID: 26485539 Free article. Clinical Trial.
36 results